Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.65
Jun. 29, 2026 16:00:00- Change -0.0008 (-0.1234%)
- Volume 114,915
- Today's Open 0.64
- Previous Close 0.6483
- Today's High 0.66
- Today's Low 0.63
- 52 Week High 1.96
- 52 Week Low 0.281